A prospective safety surveillance study for bupropion sustained-release in the treatment of depression

Journal of Clinical Psychiatry

Volumn 59, Issue 7, 1998, Pages 366-373

  Dunner, David L ^a   Zisook, Sidney ^b   Billow, Alacia A ^c   Batey, Sharyn R ^c   Johnston, J Andrew ^c   Ascher, John A ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEIZURE; SUSTAINED RELEASE PREPARATION;

EID: 0031855576     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0705     Document Type: Article

References (21)

1. Zung WWK. Review of placebo-controlled trials with bupropion. J Clin Psychiatry 1983;44(5, sec 2):104-114
2. Feighner JP, Gardner EA, Johnston JA, et al. Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry 1991;52:329-335
3. Feighner J, Hendrickson G, Miller L, et al. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder. J Clin Psychopharmacol 1986;6:27-32
4. Weisler RH, Johnston JA, Lineberry CG, et al. Comparison of bupropion and trazodone for the treatment of major depression. J Clin Psychopharmacol 1994;14:170-179
5. Mendels J, Amin MM, Chouinard G, et al. A comparative study of bupropion and amitriptyline in depressed outpatients. J Clin Psychiatry 1983;44(5, sec 2):118-120
6. Chouinard G. Bupropion and amitriptyline in the treatment of depressed patients. J Clin Psychiatry 1983;44(5, sec 2):121-129
7. Davidson J. Seizures and bupropion: a review. J Clin Psychiatry 1989;50(7):256-261
8. Johnston JA, Lineberry CG, Ascher JA, et al. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 1991;52:450-456
9. Home RL, Ferguson JL, Pope HG Jr, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988;49:262-266
10. Jick H, Dinan BJ, Hunter JR, et al. Tricyclic antidepressants and convulsions. J Clin Psychopharmacol 1983;3:182-185
11. Lowry MR, Dunner FJ. Seizures during tricyclic therapy. Am J Psychiatry 1980;137:1461-1462
12. Jick SS, Jick H, Knauss TA, et al. Antidepressants and convulsions. J Clin Psychopharmacol 1992;12:241-245
13. Peck AW, Stern WC, Watkinson C. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. J Clin Psychiatry 1983;44(5, sec 2):197-201
14. Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antide-pressants: a review. J Clin Psychiatry 1993;54:289-299
15. Markowitz JC, Brown RP. Seizures with neuroleptics and antidepressants. Gen Hosp Psychiatry 1987;9:135-141
16. Lee ET. Statistical Methods for Survival Data Analysis. Belmont, Calif: Wyeth-Ayerst Laboratories; 1980
17. Leber P. Adverse drug reactions: "time-less" risks, a hazard of risk assessment: the example of seizure and antidepressants. Psychopharmacol Bull 1985;21:334-338
18. Prozac Pulvules (fluoxetine hydrochloride) [package insert]. Indianapolis, Ind: Dista Products Company; 1997
19. Paxil tablets (paroxetine hydrochloride). [package insert]. Philadelphia, Pa: SmithKline Beecham Pharmaceuticals; 1997
20. Zoloft tablets (sertraline HCl) [package insert]. New York, NY: Pfizer Inc; 1997
21. Effexor tablets (venlafaxine HCI) [package insert]. Philadelphia, Pa: Wyeth-Ayerst Laboratories; 1997